- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: NSCLC Non-small cell lung cancer
Total 157019 results
-
UNICANCERAstraZeneca; Intergroupe Francophone de Cancerologie Thoracique; Fondation ARCCompletedNon-small Cell Lung Cancer MetastaticFrance
-
Zhejiang Cancer HospitalActive, not recruitingNon-small Cell Lung Cancer | PDL1 Gene MutationChina
-
Samsung Medical CenterAstraZenecaCompletedEfficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) (BLOSSOM)Non-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Testicular Neoplasms | Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Gastroesophageal Junction CarcinomaUnited States, Canada, Spain, Sweden, United Kingdom
-
University of FloridaMonteris MedicalTerminatedMelanoma | Primary Mediastinal Large B-Cell Lymphoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Esophageal Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Cancer | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Brain Metastases, Adult | Renal Cell... and other conditionsUnited States
-
AmgenTerminatedNSCLC | Non-small Cell Lung CancerUnited States, Austria, Australia
-
Worldwide Innovative Network AssociationPfizer; ARC Foundation for Cancer ResearchTerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBIsrael, United States, Luxembourg, Spain
-
State University of New York - Upstate Medical...CompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
SCRI Development Innovations, LLCPfizerWithdrawnLung Cancer | Non-small Cell Lung CancerUnited States
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
Prelude TherapeuticsCompletedSarcoma | Non-small Cell Lung Cancer | Castrate Resistant Prostate Cancer | Solid Tumors With Known MYC Amplification | Hormone Receptor Positive HER2 Negative Breast CancerUnited States
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States, Spain, United Kingdom, Japan, Turkey, Belgium, Germany, Netherlands, Canada, Singapore, Switzerland, Israel, Russian Federation, Korea, Republic of, Hong Kong, Lebanon, Italy, France, Portugal, Ireland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Taiwan, United States, China, Hong Kong, France, Russian Federation, Netherlands, Japan, Spain, Italy, Belgium, Vietnam, Malaysia, Thailand, Germany, Singapore
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
Promontory Therapeutics Inc.Pfizer; EMD SeronoCompletedNon-Small Cell Lung Cancer (NSCLC)United States, Switzerland
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
AstraZenecaCompletedNon-small Cell Lung Cancer (NSCLC)United Kingdom, United States, Italy, Spain, Germany, France
-
University Health Network, TorontoActive, not recruitingNon-small Cell Lung CarcinomaCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNonsmall Cell Lung Cancer | Carcinoma,Non-Small-Cell Lung | Non-small-cell Lung Carcinoma | Lung Carcinomas, Non-Small-CellSpain, Australia, Belarus, Brazil, Bulgaria, Chile, China, Colombia, Czechia, Georgia, Greece, Hungary, Jordan, Lebanon, Malaysia, Mexico, Philippines, Poland, Romania, Russian Federation, Taiwan, Thailand, Turkey, Ukraine
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
Hospital Israelita Albert EinsteinMinistry of Health, BrazilCompleted
-
BayerCompletedHepatocellular Carcinoma (HCC) | Non-small Cell Lung Cancer (NSCLC) | Head and Neck Squamous Cell Carcinoma (HNSCC)United States, Canada
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Spain
-
AstraZenecaCompleted
-
Ankara UniversityCompletedNon-small Cell Lung Cancer Stage IIITurkey
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
Sun Yat-sen UniversityCompletedNon-small Cell Lung CancerChina
-
Yuhan CorporationCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, France
-
Beijing Pearl Biotechnology Limited Liability CompanyActive, not recruitingNon-small Cell Lung CancerChina
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics IncCompletedNon-small Cell Lung CancerUnited States
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Erasca, Inc.CompletedAdvanced Non-squamous Non-small-cell Lung CancerUnited States
-
GenmabAbbVieTerminatedEsophageal Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer (NSCLC) | Uterine Cancer | Triple Negative Breast Cancer (TNBC) | Squamous Cell Carcinoma of Head and Neck (SCCHN) | Locally Advanced or Metastatic Solid Tumor(s)Spain, Israel, United States, Denmark
-
Novartis PharmaceuticalsWithdrawn
-
Fudan UniversityCompletedNon-small Cell Lung Cancer Stage I | Lymph Node MetastasesChina